Title:
SOLID ORAL DOSAGE FORM COMPRISING CEFDINIR
Document Type and Number:
WIPO Patent Application WO/2012/078121
Kind Code:
A3
Abstract:
The present invention relates to pharmaceutical compositions comprising cefdinir as active agent and a production method for preparation of said compositions.
Inventors:
BILGIC MAHMUT (TR)
Application Number:
PCT/TR2011/000273
Publication Date:
August 23, 2012
Filing Date:
December 02, 2011
Export Citation:
Assignee:
BILGIC MAHMUT (TR)
International Classes:
A61K9/48; A61K31/546; A61P31/04
Domestic Patent References:
| WO2007086078A2 | 2007-08-02 | |||
| WO2007129176A2 | 2007-11-15 | |||
| WO2011078820A1 | 2011-06-30 | |||
| WO2011078822A1 | 2011-06-30 | |||
| WO2011139249A2 | 2011-11-10 |
Foreign References:
| US20050245738A1 | 2005-11-03 | |||
| US20070128268A1 | 2007-06-07 | |||
| US20030129227A1 | 2003-07-10 | |||
| US20050131079A1 | 2005-06-16 | |||
| EP2366379A1 | 2011-09-21 |
Other References:
DATABASE WPI Section Ch Week 200729, Derwent World Patents Index; Class B02, AN 2007-297701, XP002678225, IMAI E; NIWA H: "Non-crystalline amorphous cefdinir for use in oral administration pharmaceutical composition for providing antimicrobial effect against Gram-positive and Gram-negative bacteria in oral cavity, is free from crystalline cefdinir"
DATABASE WPI Section Ch Week 201080, Derwent World Patents Index; Class A96, AN 2010-P34926, XP002678227, FANG S; JIE Q; LU M; YE F; YU B; YU M: "Cefdinir sodium bisulfate capsule comprises cefdinir sodium bisulfate, filling agent, disintegrant and lubricant, where filling agent is e.g. glucose and/or lactose, and the disintegrant is e.g. hydroxyethyl cellulose and/or alginic acid"
DATABASE WPI Section Ch Week 201001, Derwent World Patents Index; Class A96, AN 2009-N30656, XP002678226, CHOI M S; HYEON SONG S; SEOK CHOI M; SONG S H: "Pharmaceutical composition for improving dissolution rate of cefdinir, comprises carbonate, solubilizing agent, lubricant, binder, surfactant, coloring agent, buffer agent, diluent, flavoring compound, preserver and filler"
DATABASE WPI Section Ch Week 200821, Derwent World Patents Index; Class A96, AN 2008-C78111, XP002678254, LIU F: "Slow-release preparation of cefdinir in which cefdinir material is added with slow-release framework material according to a stated percentage, then made into solid dispersant with medicine material"
DATABASE WPI Section Ch Week 200925, Derwent World Patents Index; Class A96, AN 2009-F19584, XP002678228, PANG D; YANG F: "Dispersible tablet comprises specified amount of Cefdinir, and auxiliary materials including disintegrating agent, promoting agent, filler, and other auxiliary materials"
VIDHYA PRAKASH ET AL: "Oral and parenteral therapeutic options for outpatient urinary infections caused by Enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, vol. 53, no. 3, 1 March 2009 (2009-03-01), pages 1278 - 1280, XP002628190, ISSN: 0066-4804, [retrieved on 20090105], DOI: 10.1128/AAC.01519-08
DATABASE WPI Section Ch Week 201080, Derwent World Patents Index; Class A96, AN 2010-P34926, XP002678227, FANG S; JIE Q; LU M; YE F; YU B; YU M: "Cefdinir sodium bisulfate capsule comprises cefdinir sodium bisulfate, filling agent, disintegrant and lubricant, where filling agent is e.g. glucose and/or lactose, and the disintegrant is e.g. hydroxyethyl cellulose and/or alginic acid"
DATABASE WPI Section Ch Week 201001, Derwent World Patents Index; Class A96, AN 2009-N30656, XP002678226, CHOI M S; HYEON SONG S; SEOK CHOI M; SONG S H: "Pharmaceutical composition for improving dissolution rate of cefdinir, comprises carbonate, solubilizing agent, lubricant, binder, surfactant, coloring agent, buffer agent, diluent, flavoring compound, preserver and filler"
DATABASE WPI Section Ch Week 200821, Derwent World Patents Index; Class A96, AN 2008-C78111, XP002678254, LIU F: "Slow-release preparation of cefdinir in which cefdinir material is added with slow-release framework material according to a stated percentage, then made into solid dispersant with medicine material"
DATABASE WPI Section Ch Week 200925, Derwent World Patents Index; Class A96, AN 2009-F19584, XP002678228, PANG D; YANG F: "Dispersible tablet comprises specified amount of Cefdinir, and auxiliary materials including disintegrating agent, promoting agent, filler, and other auxiliary materials"
VIDHYA PRAKASH ET AL: "Oral and parenteral therapeutic options for outpatient urinary infections caused by Enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, vol. 53, no. 3, 1 March 2009 (2009-03-01), pages 1278 - 1280, XP002628190, ISSN: 0066-4804, [retrieved on 20090105], DOI: 10.1128/AAC.01519-08
Attorney, Agent or Firm:
KOSE, Meliha Merve (Merkezi Bagimsiz Bolum No:2/13, Merter/Istanbul, TR)
Download PDF: